ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis
Atherosclerosis
· Elsevier
Аннотация
Publication date: November 2026 Source: Atherosclerosis, Volume 422 Author(s): Tianlan Xi, Qian Liu, Yumei Dai, Chengju Li, Shan Li, Limei Ma, Zhiyi Yuan, Yilin Wen, Chao Yu
Читать у издателя →
Цитирование
ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis. // Atherosclerosis. – URL: https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all
ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis. Atherosclerosis. https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all
“ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis.” Atherosclerosis.
@article{article37197,
title = {ST3GAL1-mediated α-2,3 sialylation restrains CD105–TGFβRII signaling to attenuate EndMT-driven atherosclerosis},
journal = {Atherosclerosis},
url = {https://www.sciencedirect.com/science/article/pii/S0021915026012931?dgcid=rss_sd_all}
}